Giulia Bresciani
Giulia Bresciani
Section of Endocrinology and Internal Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy
Search for other papers by Giulia Bresciani in
Google Scholar
PubMed
Search for other papers by Giulia Bresciani in
Google Scholar
PubMed
Angeliki Ditsiou
Angeliki Ditsiou
Department of Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Brighton, UK
Search for other papers by Angeliki Ditsiou in
Google Scholar
PubMed
Search for other papers by Angeliki Ditsiou in
Google Scholar
PubMed
Chiara Cilibrasi
Chiara Cilibrasi
Department of Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Brighton, UK
Search for other papers by Chiara Cilibrasi in
Google Scholar
PubMed
Search for other papers by Chiara Cilibrasi in
Google Scholar
PubMed
Viviana Vella
Viviana Vella
Department of Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Brighton, UK
Search for other papers by Viviana Vella in
Google Scholar
PubMed
Search for other papers by Viviana Vella in
Google Scholar
PubMed
Federico Rea
Federico Rea
Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Padua, Italy
Search for other papers by Federico Rea in
Google Scholar
PubMed
Search for other papers by Federico Rea in
Google Scholar
PubMed
Marco Schiavon
Marco Schiavon
Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Padua, Italy
Search for other papers by Marco Schiavon in
Google Scholar
PubMed
Search for other papers by Marco Schiavon in
Google Scholar
PubMed
Narciso Giorgio Cavallesco
Narciso Giorgio Cavallesco
Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy
Search for other papers by Narciso Giorgio Cavallesco in
Google Scholar
PubMed
Search for other papers by Narciso Giorgio Cavallesco in
Google Scholar
PubMed
Georgios Giamas
Georgios Giamas
Department of Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Brighton, UK
Search for other papers by Georgios Giamas in
Google Scholar
PubMed
Search for other papers by Georgios Giamas in
Google Scholar
PubMed
Maria Chiara Zatelli
Maria Chiara Zatelli
Section of Endocrinology and Internal Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy
Search for other papers by Maria Chiara Zatelli in
Google Scholar
PubMed
Search for other papers by Maria Chiara Zatelli in
Google Scholar
PubMed
Teresa Gagliano
Teresa Gagliano
Department of Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Brighton, UK
Search for other papers by Teresa Gagliano in
Google Scholar
PubMed
Search for other papers by Teresa Gagliano in
Google Scholar
PubMed
therapeutic targets in the treatment of BP-NENs. Moreover, we have also assessed whether other RTK inhibitors, erlotinib and linsitinib, could be effective in malignancy management. Materials and methods Drugs and chemicals Sunitinib, erlotinib and
Carina Hasenoehrl
Carina Hasenoehrl
Institute of Pathophysiology and Immunology, Center of Molecular Medicine, Medical University of Graz, Graz, Austria
Search for other papers by Carina Hasenoehrl in
Google Scholar
PubMed
Search for other papers by Carina Hasenoehrl in
Google Scholar
PubMed
Gert Schwach
Gert Schwach
Institute of Pathophysiology and Immunology, Center of Molecular Medicine, Medical University of Graz, Graz, Austria
Search for other papers by Gert Schwach in
Google Scholar
PubMed
Search for other papers by Gert Schwach in
Google Scholar
PubMed
Nassim Ghaffari-Tabrizi-Wizsy
Nassim Ghaffari-Tabrizi-Wizsy
Institute of Pathophysiology and Immunology, Center of Molecular Medicine, Medical University of Graz, Graz, Austria
SFL Chicken CAM Lab, Institute of Pathophysiology and Immunology, Medical University of Graz, Graz, Austria
Search for other papers by Nassim Ghaffari-Tabrizi-Wizsy in
Google Scholar
PubMed
SFL Chicken CAM Lab, Institute of Pathophysiology and Immunology, Medical University of Graz, Graz, Austria
Search for other papers by Nassim Ghaffari-Tabrizi-Wizsy in
Google Scholar
PubMed
Robert Fuchs
Robert Fuchs
Institute of Pathophysiology and Immunology, Center of Molecular Medicine, Medical University of Graz, Graz, Austria
Search for other papers by Robert Fuchs in
Google Scholar
PubMed
Search for other papers by Robert Fuchs in
Google Scholar
PubMed
Nadine Kretschmer
Nadine Kretschmer
Department of Pharmacognosy, Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria
Search for other papers by Nadine Kretschmer in
Google Scholar
PubMed
Search for other papers by Nadine Kretschmer in
Google Scholar
PubMed
Rudolf Bauer
Rudolf Bauer
Department of Pharmacognosy, Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria
Search for other papers by Rudolf Bauer in
Google Scholar
PubMed
Search for other papers by Rudolf Bauer in
Google Scholar
PubMed
Roswitha Pfragner
Roswitha Pfragner
Institute of Pathophysiology and Immunology, Center of Molecular Medicine, Medical University of Graz, Graz, Austria
Search for other papers by Roswitha Pfragner in
Google Scholar
PubMed
Search for other papers by Roswitha Pfragner in
Google Scholar
PubMed
). In glioblastoma cells U87MG, various shikonin derivatives have been reported to have cytotoxic properties with IC 50 values ranging from 3.61 µM to 51.97 µM ( 30 ). In combination with the tyrosine kinase inhibitor erlotinib, however, synergistic
Marra Jai Aghajani
Marra Jai Aghajani
Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
Search for other papers by Marra Jai Aghajani in
Google Scholar
PubMed
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
Search for other papers by Marra Jai Aghajani in
Google Scholar
PubMed
Tara Laurine Roberts
Tara Laurine Roberts
Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
South West Sydney Clinical School, UNSW Sydney, Sydney, Australia
Search for other papers by Tara Laurine Roberts in
Google Scholar
PubMed
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
South West Sydney Clinical School, UNSW Sydney, Sydney, Australia
Search for other papers by Tara Laurine Roberts in
Google Scholar
PubMed
Tao Yang
Tao Yang
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
Saint Vincent’s Clinical School, UNSW Sydney, Sydney, Australia
SydPath, Saint Vincent’s Hospital, Sydney, Australia
Search for other papers by Tao Yang in
Google Scholar
PubMed
Saint Vincent’s Clinical School, UNSW Sydney, Sydney, Australia
SydPath, Saint Vincent’s Hospital, Sydney, Australia
Search for other papers by Tao Yang in
Google Scholar
PubMed
Charles Eugenio McCafferty
Charles Eugenio McCafferty
Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
Search for other papers by Charles Eugenio McCafferty in
Google Scholar
PubMed
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
Search for other papers by Charles Eugenio McCafferty in
Google Scholar
PubMed
Nicole J Caixeiro
Nicole J Caixeiro
Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
Centre for Oncology Education and Research Translation (CONCERT), Liverpool, New South Wales, Australia
Search for other papers by Nicole J Caixeiro in
Google Scholar
PubMed
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
Centre for Oncology Education and Research Translation (CONCERT), Liverpool, New South Wales, Australia
Search for other papers by Nicole J Caixeiro in
Google Scholar
PubMed
Paul DeSouza
Paul DeSouza
Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
South West Sydney Clinical School, UNSW Sydney, Sydney, Australia
Search for other papers by Paul DeSouza in
Google Scholar
PubMed
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
South West Sydney Clinical School, UNSW Sydney, Sydney, Australia
Search for other papers by Paul DeSouza in
Google Scholar
PubMed
Navin Niles
Navin Niles
Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
Department of Head & Neck Surgery, Liverpool Hospital, Liverpool, New South Wales, Australia
Department of Clinical Medicine, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia
Search for other papers by Navin Niles in
Google Scholar
PubMed
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
Department of Head & Neck Surgery, Liverpool Hospital, Liverpool, New South Wales, Australia
Department of Clinical Medicine, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia
Search for other papers by Navin Niles in
Google Scholar
PubMed
survival in patients with advanced EGFR-mutated non-small cell lung cancer treated with erlotinib . Lung Cancer 2016 100 . ( https://doi.org/10.1016/j.lungcan.2016.08.001 ) 27597284 28 Zhao J Zhang P Wang J Xi Q Zhao X Ji M Hu G
E T Aristizabal Prada
E T Aristizabal Prada
Department of Internal Medicine IV, Campus Grosshadern, University-Hospital, Ludwig-Maximilians-University of Munich, Munich, Germany
Search for other papers by E T Aristizabal Prada in
Google Scholar
PubMed
Search for other papers by E T Aristizabal Prada in
Google Scholar
PubMed
C J Auernhammer
C J Auernhammer
Department of Internal Medicine IV, Campus Grosshadern, University-Hospital, Ludwig-Maximilians-University of Munich, Munich, Germany
Search for other papers by C J Auernhammer in
Google Scholar
PubMed
Search for other papers by C J Auernhammer in
Google Scholar
PubMed
NET cell lines (BON1, QGP1, KRJ-I and LCC-18) ( 84 ). Combination of mTORC1 and EGFR inhibition Everolimus exhibited synergistic effects in combination with the EGFR inhibitor erlotinib on large-cell NETs and bronchial NETs with an activated
Sofia S Pereira
Sofia S Pereira
Instituto de Investigação e Inovação em Saúde (I3S), Universidade do Porto, Porto, Portugal
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Endocrine, Cardiovascular & Metabolic Research, Department of Anatomy, Multidisciplinary Unit for Biomedical Research (UMIB), Instituto de Ciências Biomédicas Abel Salazar, University of Porto (ICBAS/UP), Porto, Portugal
Search for other papers by Sofia S Pereira in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Endocrine, Cardiovascular & Metabolic Research, Department of Anatomy, Multidisciplinary Unit for Biomedical Research (UMIB), Instituto de Ciências Biomédicas Abel Salazar, University of Porto (ICBAS/UP), Porto, Portugal
Search for other papers by Sofia S Pereira in
Google Scholar
PubMed
Mariana P Monteiro
Mariana P Monteiro
Endocrine, Cardiovascular & Metabolic Research, Department of Anatomy, Multidisciplinary Unit for Biomedical Research (UMIB), Instituto de Ciências Biomédicas Abel Salazar, University of Porto (ICBAS/UP), Porto, Portugal
Search for other papers by Mariana P Monteiro in
Google Scholar
PubMed
Search for other papers by Mariana P Monteiro in
Google Scholar
PubMed
Sonir R Antonini
Sonir R Antonini
Department of Pediatrics, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil
Search for other papers by Sonir R Antonini in
Google Scholar
PubMed
Search for other papers by Sonir R Antonini in
Google Scholar
PubMed
Duarte Pignatelli
Duarte Pignatelli
Instituto de Investigação e Inovação em Saúde (I3S), Universidade do Porto, Porto, Portugal
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Department of Endocrinology, Hospital S. João, Porto, Portugal
Search for other papers by Duarte Pignatelli in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Department of Endocrinology, Hospital S. João, Porto, Portugal
Search for other papers by Duarte Pignatelli in
Google Scholar
PubMed
xenographs DZNep EZH2 (histone modifier) inhibitor BCL2 , BCL-XL and BIRC5 expression/Caspase 3 activity assay/TUNEL assay ACC cell line NCI-H295R (145) Erlotinib and NVP-AEW541 combination EGFR and IGF1R inhibitor Annexin V
